Biology of Reproduction, Vol 56, 764-770, Copyright © 1997 by Society for the Study of Reproduction

ARTICLES

Immunogenicity and contraceptive potential of a human zona pellucida 3 peptide vaccine [published erratum appears in Biol Reprod 1997 May;56(5):1361]

H Bagavant, FM Fusi, J Baisch, B Kurth, CS David and KS Tung
Department of Pathology, University of Virginia, Charlottesville 22908, USA. hb5u@uva.pcmail.virginia.edu

Immunization with zona pellucida 3 (ZP3) glycoprotein induces infertility in primates and is a target antigen for a contraceptive vaccine. However, loss of ovarian function is a long-term side effect. A possible mechanism is autoimmune ovarian disease induced by ZP3- specific autoreactive T cells, demonstrated in mice immunized with a murine ZP3 peptide in complete Freund's adjuvant. Indeed, a murine contraceptive vaccine that elicits antibodies to zona pellucida (ZP) without concomitant pathogenic T-cell activation has been achieved by a chimeric peptide (CP) consisting of a native ZP3 B-cell epitope and a foreign helper T-cell peptide. Herein, we evaluate the CP strategy in primate for human ZP3 (hZP3) vaccine development. A CP was constructed that consisted of a known helper T-cell epitope from the malarial circumsporozoite protein and a native B-cell epitope of hZP3. The human CP elicited antibodies to ZP3 in macaques without a measurable T-cell response to the hZP3 peptide. The serum antibodies reacted with macaque and human ZP and significantly inhibited human sperm binding to oocytes in vitro. Moreover, the CP elicited antibodies to human ZP in mice that lack murine major histocompatibility complex (MHC) class II molecules but express transgenic human HLA-DR3, -DQ6, or DQ8 molecules. Therefore, this study 1) provides evidence to support the feasibility of the CP strategy in hZP3 vaccine development and 2) describes a novel approach for evaluating the influence of polymorphic human MHC on vaccine immunogenicity without human immunization.

This article has been cited by other articles:

				R.-L. Xiang, F. Zhou, Y. Yang, and J.-P. Peng Construction of the Plasmid pCMV4-rZPC' DNA Vaccine and Analysis of Its Contraceptive Potential1 Biol Reprod, May 1, 2003; 68(5): 1518 - 1524. [Abstract] [Full Text] [PDF]

				H. Bagavant, C. Sharp, B. Kurth, and K. S. K. Tung Induction and Immunohistology of Autoimmune Ovarian Disease in Cynomolgus Macaques (Macaca fascicularis) Am. J. Pathol., January 1, 2002; 160(1): 141 - 149. [Abstract] [Full Text] [PDF]

				S. M. Skinner, E. S. Schwoebel, S. V. Prasad, M. Oguna, and B. S. Dunbar Mapping of Dominant B-Cell Epitopes of a Human Zona Pellucida Protein (ZP1) Biol Reprod, December 1, 1999; 61(6): 1373 - 1380. [Abstract] [Full Text]

				H. Tsubamoto, A. Hasegawa, Y. Nakata, S. Naito, N. Yamasaki, and K. Koyama Expression of Recombinant Human Zona Pellucida Protein 2 and Its Binding Capacity to Spermatozoa Biol Reprod, December 1, 1999; 61(6): 1649 - 1654. [Abstract] [Full Text]

				S. Greenhouse, P. E. Castle, and J. Dean Antibodies to human ZP3 induce reversible contraception in transgenic mice with `humanized' zonae pellucidae Hum. Reprod., March 1, 1999; 14(3): 593 - 600. [Abstract] [Full Text] [PDF]

				I.A. Lea, M.J.C. van Lierop,, E.E. Widgren, A. Grootenhuis, Y. Wen,, M. van Duin, and M.G. O'Rand A Chimeric Sperm Peptide Induces Antibodies and Strain-Specific Reversible Infertility in Mice Biol Reprod, July 1, 1998; 59(3): 527 - 536. [Abstract] [Full Text]